Purchases and Sales Made in Q2 2024 in Spero Therapeutics, Inc. (SPRO)
This table provides information about the institutional ownership of Spero Therapeutics, Inc. (SPRO) during Q2 2024. The information is specifically focused on institutions that hold shares of Spero Therapeutics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
312KNew |
$396K - $562K
|
312K
$296K
|
|
Aug 06, 2024
Q2 2024
|
Acadian Asset Management LLC
Boston, MA |
BUY
|
- |
309K+ 40.55% |
$393K - $557K
|
1.07M
$1.02M
|
|
Aug 09, 2024
Q2 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
121K+ 14.22% |
$154K - $219K
|
976K
$927K
|
|
Aug 13, 2024
Q2 2024
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
117K+ 7.08% |
$149K - $211K
|
1.77M
$1.68M
|
|
Aug 14, 2024
Q2 2024
|
Two Sigma Securities, LLC
New York, NY |
BUY
|
- |
67.7KNew |
$86K - $122K
|
67.7K
$64.3K
|
|
Aug 15, 2024
Q2 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
23.1KNew |
$29.3K - $41.5K
|
23.1K
$21.9K
|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
22.7K+ 4.85% |
$28.9K - $40.9K
|
492K
$468K
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
BUY
|
- |
6.51K+ 1.36% |
$8.26K - $11.7K
|
483K
$459K
|
|
Aug 14, 2024
Q2 2024
|
Mackenzie Financial Corp
Toronto Ontario, A6 |
BUY
|
- |
4.29K+ 15.07% |
$5.44K - $7.72K
|
32.7K
$31.1K
|
|
Aug 05, 2024
Q2 2024
|
Cullen/Frost Bankers, Inc.
|
BUY
|
- |
2KNew |
$2.54K - $3.6K
|
2K
$1.9K
|
|
Aug 14, 2024
Q2 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
1.96KNew |
$2.49K - $3.53K
|
1.96K
$1.86K
|
|
Aug 13, 2024
Q2 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
460+ 85.19% |
$584 - $828
|
1K
$950
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
366+ 7.05% |
$465 - $659
|
5.56K
$5.28K
|
|
Aug 13, 2024
Q2 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
248+ 527.66% |
$315 - $446
|
295
$280
|
|
Aug 08, 2024
Q2 2024
|
Core Cap Advisors, LLC
Southfield, MI |
BUY
|
- |
192New |
$244 - $346
|
192
$182
|
|
Aug 13, 2024
Q2 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
60+ 27.78% |
$76.2 - $108
|
276
$262
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Aug 14, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-928- 11.75% |
$1.18K - $1.67K
|
6.97K
$6.62K
|
|
Oct 17, 2024
Q2 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-928- 11.75% |
$1.18K - $1.67K
|
6.97K
$6.62K
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-2.26K- 1.97% |
$2.87K - $4.06K
|
112K
$107K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-5.4K- 94.22% |
$6.85K - $9.71K
|
331
$314
|
|
Aug 13, 2024
Q2 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-8K- 0.86% |
$10.2K - $14.4K
|
919K
$873K
|
|
Aug 14, 2024
Q2 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-49.4K- 33.38% |
$62.7K - $88.8K
|
98.5K
$93.6K
|
|
Aug 08, 2024
Q2 2024
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-72.3K- 11.9% |
$91.8K - $130K
|
535K
$509K
|
|
Aug 14, 2024
Q2 2024
|
Man Group PLC
London, X0 |
SELL
|
- |
-141K- 65.67% |
$179K - $253K
|
73.5K
$69.8K
|
|
Aug 14, 2024
Q2 2024
|
Shay Capital LLC
New York, NY |
SELL
|
- |
-282K- 91.86% |
$358K - $508K
|
25K
$23.8K
|